KALEIDO BIOSCIENCES, INC. Research and Development Expense
KALEIDO BIOSCIENCES, INC. reported Research and Development Expense of $67.80 million for the 12-month period ending 2021-12-31, per its 10-K filed 2022-04-01.
Discontinued › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2022-04-01
- KALEIDO BIOSCIENCES, INC. research and development expense for the quarter ending 2021-12-31 was $15.57M, a 8.62% increase year-over-year.
- KALEIDO BIOSCIENCES, INC. research and development expense for the quarter ending 2021-09-30 was $17.41M, a 11.19% increase year-over-year.
- KALEIDO BIOSCIENCES, INC. research and development expense for the quarter ending 2021-06-30 was $17.63M, a 37.40% increase year-over-year.
- KALEIDO BIOSCIENCES, INC. research and development expense for the quarter ending 2021-03-31 was $17.18M, a 30.81% increase year-over-year.
- KALEIDO BIOSCIENCES, INC. research and development expense for fiscal 2021 was $67.80M, a 21.15% increase from fiscal 2020.
- KALEIDO BIOSCIENCES, INC. research and development expense for fiscal 2020 was $55.97M, a 12.87% decline from fiscal 2019.
- KALEIDO BIOSCIENCES, INC. research and development expense for fiscal 2019 was $64.23M, a 52.71% increase from fiscal 2018.
- KALEIDO BIOSCIENCES, INC. research and development expense for fiscal 2018 was $42.06M.
| Period end | Research and Development Expense 3 month | Research and Development Expense 6 month | Research and Development Expense 9 month | Research and Development Expense 12 month |
|---|---|---|---|---|
| 2021-12-31 | $15.57M derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-01 | $32.98M derived: sum of 2 quarters · filed 2022-04-01 | $50.62M derived: sum of 3 quarters · filed 2022-04-01 | $67.80M 10-K · filed 2022-04-01 |
| 2021-09-30 | $17.41M 10-Q · filed 2021-11-01 | $35.04M derived: sum of 2 quarters · filed 2021-11-01 | $52.23M 10-Q · filed 2021-11-01 | $66.57M derived: sum of 4 quarters · filed 2022-04-01 |
| 2021-06-30 | $17.63M 10-Q · filed 2021-08-11 | $34.82M 10-Q · filed 2021-08-11 | $49.16M derived: sum of 3 quarters · filed 2022-04-01 | $64.81M derived: sum of 4 quarters · filed 2022-04-01 |
| 2021-03-31 | $17.18M 10-Q · filed 2021-05-04 | $31.52M derived: sum of 2 quarters · filed 2022-04-01 | $47.18M derived: sum of 3 quarters · filed 2022-04-01 | $60.02M derived: sum of 4 quarters · filed 2022-04-01 |
| 2020-12-31 | $14.34M derived: 10-K 12 month − 10-Q 9 month · filed 2022-04-01 | $30.00M derived: sum of 2 quarters · filed 2022-04-01 | $42.83M derived: sum of 3 quarters · filed 2022-04-01 | $55.97M 10-K · filed 2022-04-01 |
| 2020-09-30 | $15.66M 10-Q · filed 2021-11-01 | $28.49M derived: sum of 2 quarters · filed 2021-11-01 | $41.63M 10-Q · filed 2021-11-01 | $55.72M derived: sum of 4 quarters · filed 2021-11-01 |
| 2020-06-30 | $12.83M 10-Q · filed 2021-08-11 | $25.97M 10-Q · filed 2021-08-11 | $40.06M derived: sum of 3 quarters · filed 2021-08-11 | $56.24M derived: sum of 4 quarters · filed 2021-08-11 |
| 2020-03-31 | $13.14M 10-Q · filed 2021-05-04 | $27.22M derived: sum of 2 quarters · filed 2021-05-04 | $43.41M derived: sum of 3 quarters · filed 2021-05-04 | $62.19M derived: sum of 4 quarters · filed 2021-05-04 |
| 2019-12-31 | $14.09M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-03 | $30.27M derived: sum of 2 quarters · filed 2021-03-03 | $49.05M derived: sum of 3 quarters · filed 2021-03-03 | $64.23M 10-K · filed 2021-03-03 |
| 2019-09-30 | $16.19M 10-Q · filed 2020-11-02 | $34.96M derived: sum of 2 quarters · filed 2020-11-02 | $50.15M 10-Q · filed 2020-11-02 | $65.35M derived: sum of 4 quarters · filed 2020-11-02 |
| 2019-06-30 | $18.77M 10-Q · filed 2020-08-04 | $33.96M 10-Q · filed 2020-08-04 | $49.16M derived: sum of 3 quarters · filed 2020-08-04 | $59.33M derived: sum of 4 quarters · filed 2020-08-04 |
| 2019-03-31 | $15.18M 10-Q · filed 2020-05-14 | $30.39M derived: sum of 2 quarters · filed 2020-05-14 | $40.56M derived: sum of 3 quarters · filed 2020-05-14 | $49.70M derived: sum of 4 quarters · filed 2020-05-14 |
| 2018-12-31 | $15.21M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | $25.38M derived: sum of 2 quarters · filed 2020-03-02 | $34.52M derived: sum of 3 quarters · filed 2020-03-02 | $42.06M 10-K · filed 2020-03-02 |
| 2018-09-30 | $10.17M 10-Q · filed 2019-10-30 | $19.31M derived: sum of 2 quarters · filed 2019-10-30 | $26.85M 10-Q · filed 2019-10-30 | |
| 2018-06-30 | $9.14M 10-Q · filed 2019-08-01 | $16.69M 10-Q · filed 2019-08-01 | ||
| 2018-03-31 | $7.55M 10-Q · filed 2019-05-02 |